Frankfurt
27.02.26 | 21:43
0,019 Euro
+4,37 % +0,001
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.02. | Acarix Q4 2025 presentation: Revenue up 26% as CADScor adoption accelerates | 12 | Investing.com | ||
| 12.02. | Acarix AB: Acarix Publishes Year-End Report 2025 | 111 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end financial results. "Last year was a year of meaningful commercial and operational... ► Artikel lesen | |
| 11.02. | Acarix AB: Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System | 231 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics for coronary artery disease, today announced that it has entered into a strategic... ► Artikel lesen | |
| 04.02. | Acarix AB: Acarix Receives EU MDR Certification for the CADScorSystem | 230 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor System has successfully achieved certification under the European Union Medical... ► Artikel lesen | |
| 06.11.25 | Acarix AB Q3 Loss Drops | 9 | RTTNews | ||
| 06.11.25 | Acarix Q3 2025: Umsatzplus von 137 % beflügelt globalen Expansionskurs | 6 | Investing.com Deutsch | ||
| 06.11.25 | Acarix Q3 2025 presentation slides: 137% revenue growth amid global expansion | 5 | Investing.com | ||
| ACARIX Aktie jetzt für 0€ handeln | |||||
| 06.11.25 | Acarix AB: Acarix Publishes Interim Report, Third quarter 2025 | 161 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the third quarter of 2025. The report highlights international... ► Artikel lesen | |
| 27.10.25 | Acarix AB: Announcement from the general meeting in Acarix AB | 216 | GlobeNewswire (Europe) | The extraordinary general meeting 2025 (the "EGM") of Acarix AB ("Acarix" or the "Company") was held today on 27 October 2025 and the following resolutions were passed unanimously by the meeting.
Change... ► Artikel lesen | |
| 17.10.25 | Acarix AB: Acarix responds to G-BA decision on reimbursement in the German market | 229 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a negative decision on the possibility for CADScor System to receive reimbursement... ► Artikel lesen | |
| 21.08.25 | Acarix AB: Acarix Reports Significant Progress Toward Fixed Reimbursement | 225 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that the company has achieved another milestone on its path toward fixed reimbursement... ► Artikel lesen | |
| 21.08.25 | Acarix AB: Acarix Publishes Interim Report, January - June 2025 | 225 | GlobeNewswire (Europe) | Malmö, Sweden (Aug. 21, 2025) - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the second quarter and first half of 2025. The... ► Artikel lesen | |
| 28.07.25 | Acarix AB: Acarix achieves new Fixed U.S. reimbursement milestone for CADScor at $300.00 USD | 319 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that a second payer has agreed to provide fixed reimbursement of $300 for the CADScor®... ► Artikel lesen | |
| 08.07.25 | Acarix AB: Acarix Enters MENA Region with First Major Order, Expanding Global Presence | 318 | GlobeNewswire (Europe) | Malmö, Sweden - July 8, 2025 - Acarix, a global pioneer in AI-driven and acoustics-based cardiac diagnostics, is proud to announce its first order in the Middle East and North Africa (MENA) region.... ► Artikel lesen | |
| 26.06.25 | Acarix AB: Acarix Applauds New Peer-Reviewed Study Demonstrating Cost-Effectiveness of the CADScor System in U.S. Emergency Departments | 306 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics - Open demonstrating that the CADScor®... ► Artikel lesen | |
| 16.06.25 | Acarix AB: Acarix Achieves First Fixed U.S. Reimbursement Milestone for CADScor at $300.00 USD | 294 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide fixed reimbursement for the CADScor® System at... ► Artikel lesen | |
| 12.05.25 | Acarix AB: Acarix Publishes Interim Report, January - March 2025 | 400 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quarter of 2025. The report highlights continued growth in the U.S.... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,450 | +0,59 % | DAX-Check LIVE: Aixtron, CEWE, Elmos, FMC, MTU, SFC Energy im Fokus | Neue Zolldrohungen aus Washington haben den deutschen Aktienmarkt zum Wochenstart unter Druck gesetzt. Der DAX fiel 1,06 Prozent auf 24.991 Punkte und rutschte damit wieder unter die Marke von 25.000... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,120 | -0,59 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,420 | +1,65 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| UNITEDHEALTH | 248,15 | -0,04 % | Dividend Roundup: Home Depot, UnitedHealth, Cigna, Nvidia, and more | ||
| HIMS & HERS HEALTH | 12,285 | +0,08 % | Opening Bell: Bitcoin, AMD & Meta, Home Depot, Hims & Hers, Apple, Palo Alto | Die US-Börsen sind mit deutlichen Abschlägen in die Woche gestartet. Der Dow Jones fiel 1,66 Prozent, der Nasdaq Composite verlor 1,13 Prozent. Beide Indizes weiteten ihre anfänglichen Verluste im Tagesverlauf... ► Artikel lesen | |
| BICO GROUP | 1,696 | -0,41 % | BICO Group AB: Publication of BICO Group AB: Year-end report 2025 | Strong Lab Automation growth and higher cash balance
Q4 2025 SummaryLab Automation delivered 15 percent organic sales growth YoY. This was primarily driven by accelerated project completions and additional... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,017 | -6,59 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| SPINEWAY | 0,166 | -0,84 % | Spineway: 2025 annual results | Ecully, February 17, 2026 - 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,066 | 0,00 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| VERU | 2,560 | -4,48 % | Veru Inc.: Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress | -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter- --Company to host conference call and webcast... ► Artikel lesen | |
| CLARIANE | 4,054 | +0,05 % | Clariane: Full-year 2025 results | Solid 2025 resultsDebt reduction trajectory confirmedGrowth objectives for 2025-2028 All tables are available in the PDF. Successful plan to strengthen the financial position and confirmed debt... ► Artikel lesen | |
| VIROMED MEDICAL | 6,300 | -1,56 % | EQS-DD: Viromed Medical AG: Uwe Perbandt, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.02.2026 / 17:05... ► Artikel lesen | |
| SENSEONICS | 6,900 | -1,43 % | Senseonics Q4 2025 Earnings Preview | ||
| BONESUPPORT | 19,000 | -0,37 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes year-end report 2025 | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the year-end report for the fourth quarter and full year 2025.
"Strong growth... ► Artikel lesen |
ACARIX AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,001 (+4,37 %) liegt der Kurs bei 0,019 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACARIX AB finden Sie auf Wallstreet Online.